Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

47.03
Delayed Data
As of Sep 30
 +0.32 / +0.69%
Today’s Change
27.14
Today|||52-Week Range
80.71
-40.75%
Year-to-Date

Today’s Trading

Previous close46.71
Today’s open47.16
Day’s range46.11 - 47.22
Volume701,140
Average volume (3 months)863,210
Market cap$7.1B
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-623.81%
Earnings growth (this year)+49.30%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+1.54%
P/E ratioNM
Price/Sales18.85
Price/Book5.36

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc+0.79+1.15%
JAZZJazz Pharmaceuticals...-1.53-1.24%
SGENSeattle Genetics Inc+0.72+1.35%
RDYDr.Reddy's Laborator...+0.18+0.39%
Data as of 4:04pm ET, 09/30/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$628.3M
Annual profit (last year)-$227.2M
Net profit margin-36.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts

Search for Jobs